Goldman Sachs’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17M | Sell |
|
|||||
|
2025
Q1 | $26.7M | Buy |
|
|||||
|
2024
Q4 | $8.76M | Buy |
|
|||||
|
2024
Q3 | $6.88M | Sell |
|
|||||
|
2024
Q2 | $11.6M | Buy |
|
|||||
|
2024
Q1 | $9.13M | Sell |
|
|||||
|
2023
Q4 | $38.7M | Buy |
|
|||||
|
2023
Q3 | $14M | Buy |
|
|||||
|
2023
Q2 | $12.6M | Buy |
|
|||||
|
2023
Q1 | $14.3M | Sell |
|
|||||
|
2022
Q4 | $15M | Sell |
|
|||||
|
2022
Q3 | $38.4M | Buy |
|
|||||
|
2022
Q2 | $39.4M | Buy |
|
|||||
|
2022
Q1 | $45M | Buy |
|
|||||
|
2021
Q4 | $51.1M | Buy |
|
|||||
|
2021
Q3 | $59.4M | Sell |
|
|||||
|
2021
Q2 | $107M | Sell |
|
|||||
|
2021
Q1 | $141M | Buy |
|
|||||
|
2020
Q4 | $77.9M | Buy |
|
|||||
|
2020
Q3 | $15.4M | Sell |
|
|||||
|
2020
Q2 | $10.3M | Sell |
|
|||||
|
2020
Q1 | $10.9M | Sell |
|
|||||
|
2019
Q4 | $44.9M | Sell |
|
|||||
|
2019
Q3 | $51.2M | Buy |
|
|||||
|
2019
Q2 | $41.1M | Buy |
|
|||||
|
2019
Q1 | $42.7M | Buy |
|
|||||
|
2018
Q4 | $39.2M | Buy |
|
|||||
|
2018
Q3 | $46.9M | Sell |
|
|||||
|
2018
Q2 | $46.7M | Sell |
|
|||||
|
2018
Q1 | $80.5M | Buy |
|
|||||
|
2017
Q4 | $20.2M | Buy |
|
|||||
|
2017
Q3 | $19.1M | Buy |
|
|||||
|
2017
Q2 | $822K | Sell |
|
|||||
|
2017
Q1 | $674K | Sell |
|
|||||
|
2016
Q4 | $567K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $211K | Sell |
|
|||||
|
2016
Q1 | $807K | Buy |
|